Effect of tumor necrosis factor-α blocker (infliximab) on blastocyst development in vitro
letter
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the impact of infliximab, a tumor necrosis factor-α blocker, on blastocyst development in vitro.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (9)
- Endometriosis: novel etiopathogenetic concepts and clinical perspectives via openalex
- Immunobiology of endometriosis via openalex
- Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-α in women with endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. via openalex
- Treating endometriosis as an autoimmune disease via openalex
- W2052734866 via openalex
- W2060459202 via openalex
- W2042642675 via openalex
Cited by (2)
SciLite annotations
chemicals 2
etanercept
etanercept
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00
License: CC0
· commercial use OK